Literature DB >> 2297030

Factors prognostic of visual outcome in patients with subretinal hemorrhage.

S R Bennett1, J C Folk, C F Blodi, M Klugman.   

Abstract

We reviewed the charts of 29 patients with large subretinal hemorrhages involving the center of the fovea to evaluate factors that might be prognostic of visual outcome. The average final visual acuity was 20/480 with a mean follow-up of three years. Patients with thick hemorrhages (causing an obvious elevation of the fovea) had worse final visual acuity than patients with thin hemorrhages (P = .02). The diameter of the hemorrhage was not a significant predictor of outcome. Patients with aging macular degeneration had poorer final visual acuity (mean, 20/1,700, P = .002), and patients with choroidal ruptures had better final visual acuity, (mean 20/35, P less than .001) than the remainder of the patients. We found that the presence of aging macular degeneration was a more important predictor of the outcome of legal blindness than the thickness of the hemorrhage (P = .03). Although the prognosis in patients with subfoveal blood is generally poor, some patients have excellent return of vision.

Entities:  

Mesh:

Year:  1990        PMID: 2297030     DOI: 10.1016/s0002-9394(14)75575-8

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  57 in total

1.  Decreased choriocapillaris perfusion following surgical excision of choroidal neovascular membranes in age-related macular degeneration.

Authors:  M A Nasir; I Sugino; M A Zarbin
Journal:  Br J Ophthalmol       Date:  1997-06       Impact factor: 4.638

2.  Intravitreal anti-vascular endothelial growth factor monotherapy for large submacular hemorrhage secondary to neovascular age-related macular degeneration.

Authors:  H S Kim; H J Cho; S G Yoo; J H Kim; J I Han; T G Lee; J W Kim
Journal:  Eye (Lond)       Date:  2015-08-14       Impact factor: 3.775

3.  Quantification of retinal changes after resolution of submacular hemorrhage secondary to polypoidal choroidal vasculopathy.

Authors:  Jae Hui Kim; Young Suk Chang; Dong Won Lee; Chul Gu Kim; Jong Woo Kim
Journal:  Jpn J Ophthalmol       Date:  2017-11-29       Impact factor: 2.447

4.  Vitrectomy with subretinal tissue plasminogen activator and ranibizumab for submacular haemorrhages secondary to age-related macular degeneration: retrospective case series of 45 consecutive cases.

Authors:  J J González-López; G McGowan; E Chapman; D Yorston
Journal:  Eye (Lond)       Date:  2016-04-08       Impact factor: 3.775

5.  Prospective, randomised, controlled trial comparing suture needle drainage and argon laser drainage of subretinal fluid.

Authors:  G W Aylward; G Orr; S D Schwartz; P K Leaver
Journal:  Br J Ophthalmol       Date:  1995-08       Impact factor: 4.638

6.  Management of Acute Submacular Hemorrhage with Intravitreal Injection of Tenecteplase, Anti-vascular Endothelial Growth Factor and Gas.

Authors:  Jung Pil Lee; Jun Sang Park; Oh Woong Kwon; Yong Sung You; Soon Hyun Kim
Journal:  Korean J Ophthalmol       Date:  2016-05-18

7.  [Subretinal hemorrhage. Natural course and staging].

Authors:  S Bopp
Journal:  Ophthalmologe       Date:  2012-07       Impact factor: 1.059

8.  Evacuation of subretinal hemorrhage.

Authors:  A N Dellaporta
Journal:  Int Ophthalmol       Date:  1994       Impact factor: 2.031

9.  Radiating hemorrhage in exudative age-related macular degeneration.

Authors:  Jae Hui Kim; Young Suk Chang; Jong Woo Kim; Tae Gon Lee; Chul Gu Kim; Dong Won Lee
Journal:  Jpn J Ophthalmol       Date:  2016-07-25       Impact factor: 2.447

10.  Polypoidal choroidal vasculopathy in Korean patients with large submacular hemorrhage.

Authors:  Jin Sook Yoon; Jonghyun Lee; Sung Chul Lee; Hyoung Jun Koh; Sung Soo Kim; Oh Woong Kwon
Journal:  Yonsei Med J       Date:  2007-04-30       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.